| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |